Stemtech Corp
STEK · OTCMCIK 1511820fmd_1M39H3GT2YV8XSA8NRAX8WT1S9Wholesale Trade · Wholesale-Drugs, Proprietaries & Druggists' SundriesTemplate: Standard
Coverage: Sep 05, 2009 to Jun 30, 2026, 62 periods
| Line item | FY2017 | FY2018 | FY2019 | FY2020 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenues | – | – | – | – | 4 | 4 | 5 | 5 | 5 | 3 |
| Cost of revenue | – | – | – | – | 1 | 1 | 1 | 1 | 1 | 1 |
| Gross profit | – | – | – | – | 4 | 3 | 3 | 4 | 4 | 2 |
| Research and development | – | – | – | – | 0 | – | 0 | 0 | 0 | 0 |
| Selling, general and administrative | – | – | – | – | 4 | 5 | 7 | 7 | – | – |
| Total operating expenses | – | – | – | – | 5 | 7 | 8 | 8 | 6 | 5 |
| Operating income | (0) | (0) | (0) | – | (1) | (3) | (5) | (4) | (2) | (3) |
| Interest expense | 0 | 0 | 0 | 0 | – | 8 | – | 5 | 2 | 1 |
| Other non-operating income (expense) | – | – | – | – | (0) | (4) | (4) | (1) | (1) | (1) |
| Income before taxes | – | – | – | – | (2) | (7) | (9) | (5) | (4) | (4) |
| Income tax expense | – | – | – | – | (0) | 0 | 0 | 0 | 0 | 0 |
| Net income from continuing operations | – | – | – | – | (2) | (7) | (9) | (5) | (4) | (4) |
| Net income | (0) | (0) | (0) | – | (1) | (7) | (9) | (5) | (4) | (4) |